VivoSeq
Other

Humans

0

Pipeline Programs↗

9

Active Trials↗

8

Companies Involved↗

Humans is an early-stage landscape with 0 programs across 8 companies. The most active players are GSK, Shandong New Time Pharmaceutical Co., LTD, Huro Biotech Joint Stock Company.

Intelligence

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

84/100

Attrition Rate

13/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

GSK logo

GSK

0 programs

PreclinicalS

Shandong New Time Pharmaceutical Co., LTD

0 programs

PreclinicalH

Huro Biotech Joint Stock Company

0 programs

PreclinicalP

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

0 programs

PreclinicalS

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

0 programs

PreclinicalRegeneron logo

Regeneron

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

90

clinical trials

Completed64 · 71%
Terminated6 · 7%
Withdrawn6 · 7%
Recruiting5 · 6%
Unknown status5 · 6%
Not yet recruiting2 · 2%
Other2 · 2%

Clinical Trials

Trial Activity

90 trials

A Causal Role for Voltage-gated Cav1.2 Calcium Channels in Mediating 5G FR1 Effects on Sleep-associated Brain Health in Humans
Recruiting·—·N/A·NCT06998368·30 enrolled
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans
Recruiting·YYale University·Phase 1·NCT02781519·100 enrolled
Menthol Stimulation of Brown Adipose Tissue in Humans: Aim 1
Recruiting·IIndiana University·Phase 1·NCT07030725·24 enrolled
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II
Recruiting·YYale University·Phase 1·NCT04704271·100 enrolled
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I
Recruiting·YYale University·Phase 1·NCT02811510·40 enrolled
The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms
Active, not recruiting·—·Phase 4·NCT04336228·46 enrolled
Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans
Active, not recruiting·YYale University·Phase 1·NCT04711915·30 enrolled
The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance.
Not yet recruiting·—·N/A·NCT06872060·10 enrolled
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans
Not yet recruiting·MMayo Clinic·Phase 2·NCT06972407·80 enrolled
Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans
Completed·SShandong New Time Pharmaceutical Co., LTD·N/A·NCT07492173·76 enrolled
Safety Evaluation of Intranasal Use of DSM 32444 Postbiotic in Humans
Completed·HHuro Biotech Joint Stock Company·N/A·NCT05984004·60 enrolled
First Study in Humans With GSK206136
Completed·GSK logoGSK·Phase 1·NCT01059578·33 enrolled
Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI Study
Completed·UUniversity Hospital, Basel, Switzerland·Phase 1·NCT01951508·24 enrolled
A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans
Completed·AAbbott·Phase 1·NCT00959816·8 enrolled
Pharmacokinetics and Bioequivalence Study of HMPL-523 Acetate Tablets in Humans
Completed·HHutchmed·Phase 1·NCT07331194·54 enrolled
Page 1 of 6

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)